Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NRx Pharmaceuticals’ Zyesami yields positive data in EAP for Covid-19

pharmaceutical-technologyJune 17, 2021

Tag: NRx , Zyesami , EAP , COVID-19 , VIP

PharmaSources Customer Service